Literature DB >> 19521857

Camptothecin production by in vitro cultures and plant regeneration in Ophiorrhiza species.

Takashi Asano1, Hiroshi Sudo, Mami Yamazaki, Kazuki Saito.   

Abstract

Camptothecin derivatives are clinically used for the treatment of various human cancers. These derivatives are semi-synthesized from camptothecin which is isolated from the extracts of Camptotheca acuminata and Nothapodytes foetida. For the feasible production of camptothecin, the protocols for the tissue cultures of Ophiorrhiza species, O. pumila, O. liukiuensis and O. kuroiwai, have been established. The established aseptic plants and hairy roots produced camptothecin, and O. pumila hairy roots accumulated highest amount of camptothecin. Furthermore, we have established methods of plant regeneration from O. pumila hairy roots.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521857     DOI: 10.1007/978-1-60327-287-2_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.

Authors:  Emmanuelle Lautié; Olivier Russo; Pierre Ducrot; Jean A Boutin
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

Review 2.  Impact of novel microbial secondary metabolites on the pharma industry.

Authors:  Dulce Ramírez-Rendon; Ajit Kumar Passari; Beatriz Ruiz-Villafán; Romina Rodríguez-Sanoja; Sergio Sánchez; Arnold L Demain
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-21       Impact factor: 4.813

3.  Optimal harvest-time to maximize the annual camptothecin production by Ophiorrhiza pumila in a plant factory with artificial light.

Authors:  Ji-Yoon Lee; Eiji Goto; Hideo Yoshida; Shoko Hikosaka
Journal:  J Nat Med       Date:  2022-07-05       Impact factor: 3.192

4.  Divergent camptothecin biosynthetic pathway in Ophiorrhiza pumila.

Authors:  Mengquan Yang; Qiang Wang; Yining Liu; Xiaolong Hao; Can Wang; Yuchen Liang; Jianbo Chen; Youli Xiao; Guoyin Kai
Journal:  BMC Biol       Date:  2021-06-16       Impact factor: 7.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.